https://www.selleckchem.com/products/10058-f4.html
more experienced investigators. Disparities exist among grantees, and female investigators are underrepresented, especially among practicing surgeons. Gastrointestinal cancers are increasingly being treated with NAT before surgical resection. Currently, quality metrics are linked to the number of LNs resected to determine subsequent treatment and prognosis. We hypothesize that NAT decreases LN metastasis, downstages patients, and decreases overall lymph node yields (LNY) compared to initial surgical resection. With increasing use of NA
Like
Comment
Share
